What does GeneLink, Inc. do?

GeneLink, Inc. (GNLKQ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is GNLKQ's market cap?

GeneLink, Inc. (GNLKQ) has a market capitalization of approximately $10,601, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does GNLKQ pay a dividend?

No — GeneLink, Inc. (GNLKQ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

GeneLink, Inc. (GNLKQ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

GNLKQ

GeneLink, Inc.

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$10.60K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−97.89%CAGR −53.80%

Select date range

FromTo

Nov 24, 1998Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

GNLKQ does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$1.73M

Net Income−$2.23M

Net Margin−128.8%

Operating Cash Flow−$1.13M

Capital Expenditures$4.51K

Free Cash Flow−$1.14M

Return on Equity—

Return on Invested Capital0.0%

Net Debt$1.06M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for GNLKQ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how GNLKQ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GNLKQ and 80,000+ other tickers.

About GeneLink, Inc.

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.

CEO: Bernard L. Kasten Jr.
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 14
Website: www.genelink.com

Peers

Peers Tab

CNBX

CNBX Pharmaceuticals Inc.

Cap

$18.5K

ENDV

Endonovo Therapeutics, Inc.

Cap

$31.9K

FLHLF

Filament Health Corp.

Cap

$26.2K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About GNLKQ

What does GeneLink, Inc. do?: GeneLink, Inc. (GNLKQ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is GNLKQ's market cap?: GeneLink, Inc. (GNLKQ) has a market capitalization of approximately $10,601, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does GNLKQ pay a dividend?: No — GeneLink, Inc. (GNLKQ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is GNLKQ profitable?: GeneLink, Inc. (GNLKQ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.